Cargando…
Pharmacogenetics Update on Biologic Therapy in Psoriasis
Background and objectives: Psoriasis is a chronic immune-mediated skin disease caused by several complex factors, both environmental and genetic, many of which are still not fully understood. Nowadays, several groups of biological drugs are being used for psoriasis treatment. Although these therapie...
Autores principales: | Muñoz-Aceituno, Ester, Martos-Cabrera, Luisa, Ovejero-Benito, María Carmen, Reolid, Alejandra, Abad-Santos, Francisco, Daudén, Esteban |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766592/ https://www.ncbi.nlm.nih.gov/pubmed/33419370 http://dx.doi.org/10.3390/medicina56120719 |
Ejemplares similares
-
CNVs Associated with Different Clinical Phenotypes of Psoriasis and Anti-TNF-Induced Palmoplantar Pustulosis
por: Reolid, Alejandra, et al.
Publicado: (2022) -
Genetics of Psoriasis and Pharmacogenetics of Biological Drugs
por: Prieto-Pérez, Rocío, et al.
Publicado: (2013) -
DNA Copy Number Variation Associated with Anti-tumour Necrosis Factor Drug Response and Paradoxical Psoriasiform Reactions in Patients with Moderate-to-severe Psoriasis
por: SANZ-GARCÍA, Ancor, et al.
Publicado: (2021) -
Pharmacogenetics of Donepezil and Memantine in Healthy Subjects
por: Ovejero-Benito, María C., et al.
Publicado: (2022) -
Growth arrest and DNA damage-inducible proteins (GADD45) in psoriasis
por: Rodríguez-Jiménez, Pedro, et al.
Publicado: (2021)